Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹225.24
Market cap: ₹2,777 Cr
Revenue (annual): ₹1,713 Cr
Net profit (annual): ₹-48.80 Cr
P/E (TTM): -82.2×Sector 47.3×
Promoter holding: 68.85%+0.00% QoQ
FII holding: 0.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Other Announcement 4 Annual General Meeting 4 Management Change 3 Financial Results 3 Results Update 2 Board Meeting Date 2 Results Correction 1 Production Started 1 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

27 May 2026 16:10 IST NSE

Legal & Regulatory

Hikal Legal & Regulatory

Hikal Limited reported that external reviews of employee irregularities revealed revenue preponement issues. Involved employees were terminated, and management confirmed no financial impact on current periods.

Read the filing ↗